Published in
Elsevier, Journal of the Neurological Sciences, 1-2(332), p. 59-65
DOI: 10.1016/j.jns.2013.06.013
Links
Tools
Assessing risks of multiple sclerosis therapies
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 